findmyKOL
Clinical trialNCT00391729CompletedPhase 2Interventional

A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

SponsorAbbottEnrollment221Attention-Deficit/Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Mesa, Arizona, United States

  • Facility name not stated

    Lafayette, California, United States

  • Facility name not stated

    Oceanside, California, United States

  • Facility name not stated

    San Diego, California, United States

  • Facility name not stated

    Denver, Colorado, United States

  • Facility name not stated

    Jacksonville, Florida, United States

  • Facility name not stated

    Maitland, Florida, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    Tampa, Florida, United States

  • Facility name not stated

    Newton, Kansas, United States

  • Facility name not stated

    Farmington Hills, Michigan, United States

  • Facility name not stated

    Omaha, Nebraska, United States

  • Facility name not stated

    Bridgewater, New Jersey, United States

  • Facility name not stated

    New York, New York, United States

  • Facility name not stated

    Staten Island, New York, United States

  • Facility name not stated

    Chapel Hill, North Carolina, United States

  • Facility name not stated

    Lyndhurst, Ohio, United States

  • Facility name not stated

    Portland, Oregon, United States

  • Facility name not stated

    Charleston, South Carolina, United States

  • Facility name not stated

    Memphis, Tennessee, United States

  • Facility name not stated

    Lake Jackson, Texas, United States

  • Facility name not stated

    Herndon, Virginia, United States

  • Facility name not stated

    Middleton, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2006
Primary completion
30 Jun 2007
Completion
30 Jun 2007
Last update posted
18 Oct 2011
Registered enrollment
221
Registry id
NCT00391729

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.